Receptor, EphB4, antagonists & inhibitors
- Name
- Receptor, EphB4, antagonists & inhibitors
- Accession Number
- DBCAT001651
- Description
Not Available
- Drugs
Drug Drug Description Tesevatinib Tesevatinib has been used in trials studying the treatment of Cancer, Stomach Cancer, Brain Metastases, Esophageal Cancer, and Leptomeningeal Metastases, among others. Tesevatinib is a potent inhibitor of multiple RTKs... CGI-1842 JI-101 has been used in trials studying the treatment of Cancer, Colon Cancer, Neuroendocrine, Ovarian Cancer, and Advanced Solid Tumors. - Drugs & Drug Targets
Drug Target Type Tesevatinib Pro-epidermal growth factor target Tesevatinib Ephrin type-B receptor 4 target Tesevatinib Receptor tyrosine-protein kinase erbB-2 target